ADO-TRASTUZUMAB EMTANSINE

ADO-TRASTUZUMAB EMTANSINE was reported 8459 times

ADO-TRASTUZUMAB EMTANSINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HER2 POSITIVE SALIVARY GLAND CANCER 6 0.4286
1 HEPATOPULMONARY SYNDROME 25 0.1748
2 NAIL BED INFLAMMATION 38 0.1191
3 RADICAL MASTECTOMY 5 0.1064
4 PARAVENOUS DRUG ADMINISTRATION 4 0.0930
5 HER-2 POSITIVE BREAST CANCER 13 0.0929
6 GASTROINTESTINAL SUBMUCOSAL TUMOUR 4 0.0870
7 HEART FAILURE WITH MIDRANGE EJECTION FRACTION 5 0.0847
8 NODULAR REGENERATIVE HYPERPLASIA 53 0.0826
9 SPIDER NAEVUS 15 0.0811
10 SUBCAPSULAR HEPATIC HAEMATOMA 4 0.0784
11 HER2 POSITIVE BREAST CANCER 28 0.0747
12 RADIATION NECROSIS 41 0.0716
13 NAIL BED TENDERNESS 8 0.0702
14 PLEURAL NEOPLASM 11 0.0667
15 VESSEL PUNCTURE SITE BRUISE 13 0.0653
16 NASAL MUCOSAL DISORDER 38 0.0652
17 BLOOD URIC ACID DECREASED 28 0.0576
18 EJECTION FRACTION 33 0.0568
19 MICROVASCULAR CORONARY ARTERY DISEASE 12 0.0558
20 EOSINOPHIL PERCENTAGE INCREASED 27 0.0499
21 METASTASES TO SKIN 48 0.0465
22 STREPTOCOCCAL SEPSIS 52 0.0438
23 VASCULAR ACCESS SITE HAEMORRHAGE 7 0.0435
24 ANAL ERYTHEMA 5 0.0400
25 NAIL DYSTROPHY 20 0.0357
26 BREAST NEOPLASM 36 0.0349
27 HAND DERMATITIS 24 0.0346
28 NON-CIRRHOTIC PORTAL HYPERTENSION 13 0.0346
29 INFLAMMATORY CARCINOMA OF THE BREAST 5 0.0345
30 TUMOUR MARKER ABNORMAL 11 0.0332
31 CATHETER SITE INJURY 7 0.0329
32 SCINTILLATING SCOTOMA 7 0.0318
33 METASTASES TO CENTRAL NERVOUS SYSTEM 409 0.0317
34 PSEUDOMONAL SEPSIS 52 0.0297
35 LEFT VENTRICULAR DILATATION 14 0.0274
36 METASTASES TO BREAST 9 0.0271
37 METASTASES TO SOFT TISSUE 7 0.0270
38 HEMIANOPIA 26 0.0262
39 WATER INTOXICATION 13 0.0257
40 BREAST HAEMORRHAGE 8 0.0242
41 DENTAL FISTULA 10 0.0240
42 MEAN PLATELET VOLUME DECREASED 20 0.0238
43 BREAST DISORDER 48 0.0235
44 METASTASES TO LYMPH NODES 157 0.0232
45 ARTERIOVENOUS MALFORMATION 21 0.0231
46 TOXIC NEUROPATHY 9 0.0228
47 BREAST INFLAMMATION 7 0.0227
48 HORMONE RECEPTOR POSITIVE BREAST CANCER 6 0.0221
49 PORTAL HYPERTENSION 68 0.0220
50 BREAST CANCER RECURRENT 66 0.0209
51 METASTASES TO SPINAL CORD 4 0.0206
52 LYMPHANGIOSIS CARCINOMATOSA 21 0.0202
53 GASTRIC VARICES 9 0.0191
54 RADIATION SKIN INJURY 22 0.0190
55 PORTAL FIBROSIS 4 0.0187
56 BREAST OPERATION 15 0.0183
57 SALIVARY GLAND CANCER 9 0.0183
58 METASTASES TO PLEURA 19 0.0181
59 CATHETER SITE INFLAMMATION 10 0.0178
60 TELANGIECTASIA 17 0.0176
61 VASCULAR DEVICE INFECTION 79 0.0174
62 FOCAL NODULAR HYPERPLASIA 9 0.0173
63 METASTASES TO CHEST WALL 6 0.0173
64 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 21 0.0169
65 IMMUNE-MEDIATED CHOLANGITIS 6 0.0167
66 FOLATE DEFICIENCY 19 0.0164
67 CORNEAL LESION 5 0.0162
68 AXILLARY VEIN THROMBOSIS 6 0.0162
69 NAIL BED BLEEDING 9 0.0158
70 BONE MARROW INFILTRATION 6 0.0155
71 AXILLARY PAIN 23 0.0154
72 TUMOUR PAIN 20 0.0152
73 BREAST CANCER METASTATIC 160 0.0149
74 EXCESSIVE EYE BLINKING 22 0.0149
75 METASTASES TO THE MEDIASTINUM 6 0.0146
76 BLOOD CREATININE DECREASED 45 0.0144
77 NEUROMUSCULAR TOXICITY 5 0.0142
78 METASTASES TO LUNG 162 0.0140
79 CENTRAL NERVOUS SYSTEM INFECTION 16 0.0140
80 RECURRENT CANCER 57 0.0140
81 PERIPHERAL SENSORIMOTOR NEUROPATHY 17 0.0135
82 POST PROCEDURAL PNEUMONIA 4 0.0133
83 NAIL TOXICITY 4 0.0133
84 EJECTION FRACTION DECREASED 206 0.0132
85 BONE CANCER METASTATIC 7 0.0132
86 CARBOHYDRATE ANTIGEN 19-9 INCREASED 7 0.0132
87 INTRACRANIAL TUMOUR HAEMORRHAGE 5 0.0129
88 NAIL INFECTION 18 0.0126
89 OESOPHAGEAL CANCER METASTATIC 4 0.0125
90 TUMOUR MARKER INCREASED 57 0.0119
91 PARONYCHIA 52 0.0118
92 PELVIC NEOPLASM 4 0.0116
93 BLADDER IRRITATION 7 0.0109
94 ONYCHOLYSIS 17 0.0109
95 CARCINOEMBRYONIC ANTIGEN INCREASED 21 0.0108
96 BILIARY SEPSIS 5 0.0108
97 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 18 0.0108
98 METASTASES TO SPINE 36 0.0107
99 MENINGISM 5 0.0107
100 BREAST RECONSTRUCTION 4 0.0106
101 LYMPHOEDEMA 73 0.0105
102 CARBOHYDRATE ANTIGEN 15-3 INCREASED 8 0.0105
103 INTERCEPTED PRODUCT STORAGE ERROR 37 0.0104
104 COMPUTERISED TOMOGRAM THORAX ABNORMAL 7 0.0102
105 MEAN PLATELET VOLUME INCREASED 6 0.0099
106 BLOOD BILIRUBIN DECREASED 6 0.0097
107 INVASIVE BREAST CARCINOMA 4 0.0097
108 ELECTRIC SHOCK SENSATION 27 0.0096
109 RETROPERITONEAL LYMPHADENOPATHY 5 0.0095
110 GASTRIC NEOPLASM 6 0.0095
111 RADIATION PNEUMONITIS 20 0.0093
112 METASTASIS 66 0.0092
113 MASTECTOMY 16 0.0091
114 LEFT VENTRICULAR DYSFUNCTION 61 0.0091
115 HELICOBACTER TEST POSITIVE 5 0.0089
116 HYPOTHALAMO-PITUITARY DISORDER 13 0.0089
117 AUTONOMIC NEUROPATHY 9 0.0089
118 DYSCHEZIA 27 0.0088
119 GASTROINTESTINAL BACTERIAL INFECTION 10 0.0087
120 PITUITARY TUMOUR 13 0.0087
121 BLOOD PRESSURE SYSTOLIC DECREASED 39 0.0086
122 METASTASES TO BONE 140 0.0085
123 CARDIOTOXICITY 76 0.0085
124 PRIMARY BILIARY CHOLANGITIS 4 0.0085
125 INTRACRANIAL MASS 8 0.0085
126 HYDROTHORAX 7 0.0084
127 RED CELL DISTRIBUTION WIDTH INCREASED 35 0.0084
128 RECALL PHENOMENON 7 0.0084
129 BONE NEOPLASM 9 0.0083
130 METASTASES TO MENINGES 19 0.0083
131 VASOGENIC CEREBRAL OEDEMA 6 0.0083
132 HEPATIC MASS 16 0.0083
133 TUMOUR INVASION 4 0.0082
134 VARICOSE VEIN 42 0.0081
135 ANORECTAL DISORDER 16 0.0080
136 DILATED CARDIOMYOPATHY 8 0.0079
137 TUMOUR NECROSIS 8 0.0076
138 THROMBOCYTOPENIC PURPURA 10 0.0073
139 VULVOVAGINAL PAIN 35 0.0073
140 POLYNEUROPATHY 86 0.0072
141 BLOOD PRESSURE DIASTOLIC DECREASED 53 0.0072
142 MONOCYTE COUNT INCREASED 26 0.0072
143 INTERCEPTED MEDICATION ERROR 33 0.0071
144 MUCOSAL DISORDER 7 0.0070
145 HEPATIC CANCER METASTATIC 6 0.0070
146 ONYCHALGIA 7 0.0070
147 BLOOD BILIRUBIN UNCONJUGATED INCREASED 5 0.0069
148 DISEASE PROGRESSION 807 0.0068
149 CATHETER SITE HAEMORRHAGE 17 0.0068
150 VULVOVAGINAL CANDIDIASIS 9 0.0067
151 VARICES OESOPHAGEAL 20 0.0066
152 TROPONIN I INCREASED 11 0.0066
153 SOFT TISSUE INFECTION 12 0.0066
154 ASTHENOPIA 36 0.0065
155 EJECTION FRACTION ABNORMAL 8 0.0065
156 MALIGNANT PLEURAL EFFUSION 11 0.0065
157 METASTATIC NEOPLASM 28 0.0065
158 ADENOCARCINOMA GASTRIC 6 0.0065
159 MUCOSAL DRYNESS 13 0.0064
160 VASCULAR RUPTURE 10 0.0064
161 LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT 4 0.0064
162 BILIARY TRACT INFECTION 4 0.0064
163 PERFORMANCE STATUS DECREASED 30 0.0064
164 ACARODERMATITIS 7 0.0064
165 BLOOD LACTATE DEHYDROGENASE INCREASED 101 0.0064
166 OSTEOSCLEROSIS 10 0.0063
167 BRAIN ABSCESS 16 0.0063
168 SOFT TISSUE DISORDER 7 0.0063
169 PERITONEAL DISORDER 4 0.0062
170 METASTASES TO LIVER 107 0.0061
171 DEVICE RELATED SEPSIS 12 0.0060
172 BRAIN OEDEMA 75 0.0059
173 CORNEAL DISORDER 13 0.0059
174 CARDIAC DYSFUNCTION 22 0.0059
175 PERIPHERAL SENSORY NEUROPATHY 34 0.0058
176 COMPUTERISED TOMOGRAM ABNORMAL 13 0.0057
177 BLOOD POTASSIUM ABNORMAL 15 0.0056
178 HAEMANGIOMA 13 0.0056
179 PARAPARESIS 10 0.0056
180 HYPERTRANSAMINASAEMIA 39 0.0056
181 VENTRICULAR HYPOKINESIA 18 0.0056
182 CERVICAL RADICULOPATHY 4 0.0056
183 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 129 0.0055
184 GASTRIC INFECTION 21 0.0055
185 MEAN CELL HAEMOGLOBIN INCREASED 9 0.0054
186 METASTASES TO ADRENALS 5 0.0054
187 ENTEROCOLITIS INFECTIOUS 5 0.0054
188 CEREBRAL VASOCONSTRICTION 4 0.0054
189 CORNEAL DEPOSITS 4 0.0054
190 HYPERAESTHESIA 44 0.0054
191 HYPERMETROPIA 5 0.0053
192 ONYCHOMADESIS 22 0.0052
193 SERUM FERRITIN DECREASED 9 0.0052
194 COAGULATION TEST ABNORMAL 4 0.0052
195 BLOOD PHOSPHORUS DECREASED 19 0.0052
196 NEUROLOGICAL DECOMPENSATION 12 0.0052
197 HYPERTROPHIC CARDIOMYOPATHY 8 0.0052
198 CARBON DIOXIDE INCREASED 7 0.0051
199 BLOOD MAGNESIUM DECREASED 44 0.0051
200 CANCER PAIN 13 0.0051
201 SKIN FISSURES 98 0.0050
202 HEPATIC CYST 17 0.0050
203 HAEMANGIOMA OF LIVER 5 0.0050
204 HEPATOTOXICITY 110 0.0049
205 GINGIVAL BLEEDING 67 0.0049
206 ACNE PUSTULAR 4 0.0049
207 POST HERPETIC NEURALGIA 7 0.0049
208 ACUTE PROMYELOCYTIC LEUKAEMIA 5 0.0049
209 EXTRAVASATION 20 0.0049
210 HEPATIC LESION 21 0.0049
211 NEUROPATHY PERIPHERAL 457 0.0048
212 INVASIVE DUCTAL BREAST CARCINOMA 13 0.0048
213 MYELOSUPPRESSION 172 0.0048
214 HYDROCEPHALUS 26 0.0048
215 CEREBRAL HAEMATOMA 16 0.0048
216 BLOOD CHLORIDE DECREASED 12 0.0046
217 DACRYOSTENOSIS ACQUIRED 6 0.0046
218 CANDIDA INFECTION 78 0.0046
219 CARDIAC OUTPUT DECREASED 4 0.0045
220 PARANASAL SINUS DISCOMFORT 17 0.0045
221 VOCAL CORD PARALYSIS 8 0.0045
222 POOR PERIPHERAL CIRCULATION 19 0.0045
223 LUNG NEOPLASM 19 0.0044
224 BLOOD ALKALINE PHOSPHATASE INCREASED 110 0.0044
225 HYPERCHLORHYDRIA 26 0.0044
226 SUBCLAVIAN VEIN THROMBOSIS 5 0.0044
227 KLEBSIELLA INFECTION 22 0.0043
228 THROMBOCYTOPENIA 485 0.0043
229 EPISTAXIS 322 0.0043
230 PNEUMONITIS 117 0.0043
231 DERMATITIS ACNEIFORM 26 0.0043
232 HEPATIC CONGESTION 4 0.0042
233 HAEMATOTOXICITY 40 0.0042
234 TUMOUR HAEMORRHAGE 12 0.0042
235 LYMPHADENOPATHY MEDIASTINAL 8 0.0042
236 BODY TEMPERATURE DECREASED 41 0.0042
237 GAMMA-GLUTAMYLTRANSFERASE INCREASED 92 0.0041
238 HYPERBILIRUBINAEMIA 43 0.0041
239 PLATELET COUNT DECREASED 438 0.0041
240 LYMPHADENECTOMY 4 0.0041
241 SKIN TOXICITY 23 0.0041
242 PULMONARY MASS 60 0.0040
243 BLOOD UREA DECREASED 5 0.0040
244 INTRADUCTAL PROLIFERATIVE BREAST LESION 5 0.0040
245 NASAL DRYNESS 25 0.0040
246 FAECES SOFT 29 0.0040
247 PLEURITIC PAIN 11 0.0040
248 GASTROINTESTINAL TOXICITY 19 0.0040
249 INTRACRANIAL PRESSURE INCREASED 22 0.0039
250 BLOOD BILIRUBIN INCREASED 106 0.0039
251 GINGIVAL PAIN 31 0.0039
252 NEOPLASM PROGRESSION 134 0.0038
253 THERAPY PARTIAL RESPONDER 60 0.0038
254 EOSINOPHIL COUNT INCREASED 32 0.0038
255 HEPATIC CIRRHOSIS 72 0.0038
256 URINARY TRACT DISORDER 17 0.0038
257 NAIL DISORDER 32 0.0037
258 ONYCHOCLASIS 25 0.0036
259 BRAIN NEOPLASM 33 0.0036
260 MUCOSAL INFLAMMATION 93 0.0035
261 SKIN WOUND 6 0.0035
262 ODYNOPHAGIA 21 0.0035
263 PULMONARY GRANULOMA 4 0.0035
264 NEOPLASM 40 0.0035
265 THORACIC VERTEBRAL FRACTURE 10 0.0034
266 HEPATIC NEOPLASM 11 0.0034
267 BONE LESION 12 0.0033
268 NAIL DISCOLOURATION 13 0.0033
269 BLOOD TEST ABNORMAL 46 0.0033
270 WOUND DEHISCENCE 11 0.0033
271 CARBOHYDRATE ANTIGEN 125 INCREASED 11 0.0032
272 NEOPLASM SKIN 5 0.0032
273 ASPARTATE AMINOTRANSFERASE INCREASED 171 0.0032
274 IMMUNE THROMBOCYTOPENIC PURPURA 9 0.0032
275 LYMPHOCYTE COUNT DECREASED 56 0.0032
276 CEREBRAL DISORDER 23 0.0031
277 CARDIAC VENTRICULAR THROMBOSIS 4 0.0031
278 BILIARY OBSTRUCTION 4 0.0031
279 VENTRICULAR DYSFUNCTION 8 0.0031
280 HYPERAEMIA 6 0.0030
281 HEPATIC PAIN 13 0.0030
282 BLOOD ALBUMIN DECREASED 24 0.0030
283 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 7 0.0030
284 ADMINISTRATION SITE EXTRAVASATION 3 0.0030
285 TRANSAMINASES INCREASED 66 0.0030
286 ALANINE AMINOTRANSFERASE INCREASED 182 0.0030
287 LEUKOENCEPHALOPATHY 11 0.0030
288 IRON DEFICIENCY ANAEMIA 27 0.0029
289 ULCERATIVE KERATITIS 8 0.0029
290 HEPATIC FIBROSIS 10 0.0029
291 BILIARY TRACT DISORDER 4 0.0029
292 SECOND PRIMARY MALIGNANCY 24 0.0029
293 ANAL HAEMORRHAGE 8 0.0029
294 PERIPHERAL MOTOR NEUROPATHY 4 0.0029
295 DRY THROAT 29 0.0029
296 VENOOCCLUSIVE LIVER DISEASE 14 0.0028
297 INDURATION 5 0.0028
298 FOOD POISONING 15 0.0028
299 OESOPHAGEAL VARICES HAEMORRHAGE 6 0.0028
300 MEAN CELL VOLUME INCREASED 7 0.0027
301 COCCYDYNIA 4 0.0027
302 INJECTION SITE EXTRAVASATION 33 0.0027
303 PLEURAL EFFUSION 162 0.0027
304 CATHETER SITE INFECTION 10 0.0026
305 BLOOD BICARBONATE DECREASED 5 0.0026
306 ASTIGMATISM 4 0.0026
307 BRAIN OPERATION 6 0.0026
308 ERYSIPELAS 13 0.0026
309 INFUSION RELATED REACTION 171 0.0026
310 ANORGASMIA 7 0.0026
311 RESPIRATORY TRACT INFECTION VIRAL 6 0.0026
312 SPLENOMEGALY 30 0.0026
313 ORAL FUNGAL INFECTION 7 0.0026
314 BREAST MASS 17 0.0025
315 BONE CANCER 11 0.0025
316 MALIGNANT NEOPLASM PROGRESSION 259 0.0025
317 VULVOVAGINAL DRYNESS 8 0.0025
318 BRAIN NEOPLASM MALIGNANT 11 0.0025
319 MOUTH HAEMORRHAGE 18 0.0025
320 BLOOD IRON DECREASED 29 0.0024
321 BLOOD SODIUM DECREASED 46 0.0024
322 BLOOD PRESSURE SYSTOLIC ABNORMAL 6 0.0024
323 HYPOKALAEMIA 112 0.0024
324 INTERSTITIAL LUNG DISEASE 115 0.0024
325 ENTERITIS 15 0.0023
326 HAEMOLYSIS 18 0.0023
327 HYPOALBUMINAEMIA 18 0.0023
328 HEPATITIS TOXIC 6 0.0023
329 DYSAESTHESIA 7 0.0023
330 BREAST DISCHARGE 4 0.0023
331 DIASTOLIC DYSFUNCTION 7 0.0023
332 PULMONARY TOXICITY 16 0.0023
333 TEMPOROMANDIBULAR JOINT SYNDROME 6 0.0022
334 NEUTROPENIC SEPSIS 16 0.0022
335 C-REACTIVE PROTEIN INCREASED 81 0.0022
336 ASCITES 65 0.0022
337 BLOOD LOSS ANAEMIA 5 0.0022
338 HEPATIC CYTOLYSIS 28 0.0022
339 APHTHOUS ULCER 17 0.0022
340 MEAN CELL HAEMOGLOBIN DECREASED 4 0.0022
341 LACRIMATION INCREASED 66 0.0022
342 STOMATITIS 129 0.0021
343 HYPERPYREXIA 9 0.0021
344 DYSMENORRHOEA 28 0.0021
345 BILE DUCT OBSTRUCTION 4 0.0021
346 HYPOPROTEINAEMIA 4 0.0021
347 HICCUPS 17 0.0021
348 SKIN INFECTION 23 0.0020
349 LIVER DISORDER 90 0.0020
350 SUSPECTED COUNTERFEIT PRODUCT 8 0.0020
351 PNEUMOTHORAX 32 0.0020
352 CELL DEATH 4 0.0020
353 HYPOMAGNESAEMIA 28 0.0020
354 HEPATIC FUNCTION ABNORMAL 75 0.0020
355 LIVER FUNCTION TEST INCREASED 43 0.0020
356 SEASONAL ALLERGY 28 0.0020
357 IMMUNE THROMBOCYTOPENIA 9 0.0020
358 ISCHAEMIA 9 0.0020
359 OSTEOLYSIS 4 0.0020
360 FIBROSIS 6 0.0019
361 BLOOD PRESSURE SYSTOLIC INCREASED 38 0.0019
362 SKIN MASS 13 0.0019
363 AORTIC ARTERIOSCLEROSIS 5 0.0019
364 VENOUS THROMBOSIS LIMB 4 0.0019
365 NEUTROPHIL COUNT DECREASED 79 0.0019
366 TOOTHACHE 35 0.0019
367 APPENDICITIS 18 0.0019
368 NEUROLOGICAL SYMPTOM 11 0.0019
369 SUBILEUS 4 0.0019
370 RED BLOOD CELL COUNT DECREASED 54 0.0019
371 LYMPHADENOPATHY 66 0.0019
372 PORTAL VEIN THROMBOSIS 6 0.0019
373 LIVER ABSCESS 6 0.0018
374 PERIODONTITIS 4 0.0018
375 HEPATITIS 47 0.0018
376 BLOOD PHOSPHORUS INCREASED 5 0.0018
377 HENOCH-SCHONLEIN PURPURA 4 0.0018
378 HEPATIC ENCEPHALOPATHY 17 0.0018
379 PULMONARY ARTERIAL HYPERTENSION 26 0.0018
380 ILL-DEFINED DISORDER 109 0.0018
381 SPINAL PAIN 21 0.0018
382 CONJUNCTIVITIS 33 0.0018
383 PATHOLOGICAL FRACTURE 9 0.0018
384 NEOPLASM RECURRENCE 6 0.0018
385 DEVICE RELATED INFECTION 27 0.0018
386 LUNG CANCER METASTATIC 5 0.0017
387 NEURALGIA 42 0.0017
388 TONSILLITIS 9 0.0017
389 PARTIAL SEIZURES 9 0.0017
390 FEBRILE NEUTROPENIA 114 0.0017
391 BILIRUBIN CONJUGATED INCREASED 4 0.0017
392 HEART RATE DECREASED 60 0.0017
393 HEPATOCELLULAR INJURY 24 0.0017
394 BONE PAIN 99 0.0017
395 MYOPIA 4 0.0017
396 COMPRESSION FRACTURE 9 0.0017
397 VARICELLA 4 0.0017
398 PROTHROMBIN TIME PROLONGED 10 0.0017
399 GINGIVITIS 9 0.0017
400 HUMERUS FRACTURE 8 0.0017
401 PAINFUL RESPIRATION 4 0.0017
402 HEPATIC ENZYME INCREASED 113 0.0017
403 BONE MARROW DISORDER 5 0.0017
404 KERATITIS 5 0.0016
405 ABNORMAL SENSATION IN EYE 7 0.0016
406 HEPATIC ENZYME ABNORMAL 8 0.0016
407 EPILEPSY 49 0.0016
408 BREAST PAIN 17 0.0016
409 PLATELET DISORDER 4 0.0016
410 PULMONARY OEDEMA 71 0.0016
411 PULMONARY FIBROSIS 30 0.0016
412 HAEMATOCRIT DECREASED 31 0.0016
413 COAGULOPATHY 26 0.0016
414 HEPATIC FAILURE 47 0.0016
415 HEAVY MENSTRUAL BLEEDING 14 0.0016
416 CELLULITIS 78 0.0015
417 OSTEONECROSIS OF JAW 38 0.0015
418 HEPATOMEGALY 15 0.0015
419 PRODUCT PREPARATION ISSUE 10 0.0015
420 OBSTRUCTION 6 0.0015
421 VAGINAL DISCHARGE 15 0.0015
422 BONE DISORDER 27 0.0015
423 POSTOPERATIVE WOUND INFECTION 10 0.0015
424 RESTLESSNESS 54 0.0015
425 PERICARDIAL EFFUSION 34 0.0015
426 ESCHERICHIA INFECTION 12 0.0015
427 NODULE 19 0.0015
428 TENOSYNOVITIS 4 0.0014
429 HAIR GROWTH ABNORMAL 10 0.0014
430 APHONIA 20 0.0014
431 NEUTROPENIA 194 0.0014
432 SKIN HYPERTROPHY 4 0.0014
433 ALANINE AMINOTRANSFERASE ABNORMAL 3 0.0014
434 BUNDLE BRANCH BLOCK LEFT 6 0.0014
435 RETINAL DETACHMENT 13 0.0014
436 ORGANISING PNEUMONIA 7 0.0014
437 BREAST CANCER STAGE IV 4 0.0014
438 SNEEZING 31 0.0014
439 MADAROSIS 16 0.0014
440 BREAST CANCER 128 0.0014
441 AMMONIA INCREASED 7 0.0014
442 PULMONARY PAIN 4 0.0014
443 NEUROTOXICITY 24 0.0014
444 CARDIAC FAILURE ACUTE 9 0.0013
445 HYPERTENSIVE CRISIS 15 0.0013
446 CEREBRAL HAEMORRHAGE 48 0.0013
447 HYPERLIPIDAEMIA 16 0.0013
448 JAUNDICE 36 0.0013
449 BLOOD CALCIUM DECREASED 15 0.0013
450 SEIZURE 154 0.0013
451 PROTEIN TOTAL DECREASED 5 0.0013
452 MITRAL VALVE INCOMPETENCE 15 0.0013
453 LIVER FUNCTION TEST ABNORMAL 38 0.0013
454 LOWER RESPIRATORY TRACT INFECTION 59 0.0013
455 PNEUMOCYSTIS JIROVECII PNEUMONIA 13 0.0013
456 ORAL HERPES 25 0.0013
457 INTENTIONAL PRODUCT USE ISSUE 112 0.0013
458 IRIDOCYCLITIS 4 0.0013
459 WHITE BLOOD CELL COUNT DECREASED 137 0.0013
460 VIRAL UPPER RESPIRATORY TRACT INFECTION 6 0.0013
461 ECZEMA 66 0.0013
462 TOOTH DISORDER 28 0.0013
463 NO ADVERSE EVENT 228 0.0013
464 NECROSIS 7 0.0013
465 PNEUMONIA VIRAL 4 0.0013
466 LUNG INFILTRATION 11 0.0012
467 CONSTIPATION 271 0.0012
468 PAIN IN JAW 35 0.0012
469 ANAEMIA 235 0.0012
470 NEUTROPHILIA 7 0.0012
471 BODY TEMPERATURE INCREASED 25 0.0012
472 CYTOPENIA 15 0.0012
473 LIVER INJURY 30 0.0012
474 GOITRE 5 0.0012
475 CORONAVIRUS INFECTION 8 0.0012
476 HEMIPLEGIA 10 0.0012
477 NEPHRITIS 4 0.0012
478 BLOOD POTASSIUM DECREASED 36 0.0012
479 DERMATITIS 25 0.0012
480 CLOSTRIDIUM DIFFICILE INFECTION 26 0.0012
481 ATAXIA 14 0.0012
482 DRUG-INDUCED LIVER INJURY 37 0.0012
483 HAEMORRHOIDS 23 0.0012
484 PLEURISY 7 0.0012
485 CHOLECYSTITIS 14 0.0012
486 DRY MOUTH 94 0.0012
487 GRANULOMA 4 0.0012
488 NERVOUS SYSTEM DISORDER 36 0.0012
489 CHOLESTASIS 22 0.0011
490 INCORRECT PRODUCT STORAGE 15 0.0011
491 NASOPHARYNGITIS 210 0.0011
492 WEIGHT DECREASED 317 0.0011
493 THROMBOTIC THROMBOCYTOPENIC PURPURA 4 0.0011
494 GINGIVAL SWELLING 5 0.0011
495 DRUG RESISTANCE 29 0.0011
496 PRODUCT PREPARATION ERROR 23 0.0011
497 MUSCLE DISORDER 9 0.0011
498 OVARIAN CYST 11 0.0011
499 CUTANEOUS VASCULITIS 4 0.0011
500 EAR PAIN 21 0.0011
501 BLOOD CREATINE PHOSPHOKINASE INCREASED 31 0.0011
502 HEPATIC STEATOSIS 20 0.0011
503 HYPONATRAEMIA 60 0.0011
504 ORAL CANDIDIASIS 14 0.0011
505 PANCYTOPENIA 59 0.0011
506 PETECHIAE 11 0.0011
507 ENDOMETRIOSIS 5 0.0010
508 THYROID MASS 4 0.0010
509 FULL BLOOD COUNT ABNORMAL 11 0.0010
510 ENTEROCOLITIS 6 0.0010
511 VITAMIN D DEFICIENCY 10 0.0010
512 TUMOUR LYSIS SYNDROME 9 0.0010
513 MYALGIA 172 0.0010
514 OBESITY 16 0.0010
515 HYPOCALCAEMIA 19 0.0010
516 HYPERAMMONAEMIA 5 0.0010
517 CYSTITIS HAEMORRHAGIC 4 0.0010
518 BONE MARROW FAILURE 20 0.0010
519 PYREXIA 338 0.0010
520 DEMYELINATION 4 0.0010
521 FATIGUE 759 0.0010
522 PRODUCT TEMPERATURE EXCURSION ISSUE 5 0.0010
523 MUSCULOSKELETAL CHEST PAIN 15 0.0010
524 PARAESTHESIA 152 0.0010
525 COMPLICATION ASSOCIATED WITH DEVICE 14 0.0010
526 PERIORBITAL OEDEMA 5 0.0010
527 URINARY TRACT INFECTION 164 0.0010
528 CATARACT 57 0.0010
529 CHILLS 112 0.0010
530 HYPOAESTHESIA 143 0.0010
531 CARDIOMYOPATHY 14 0.0009
532 AORTIC VALVE INCOMPETENCE 4 0.0009
533 LUNG DISORDER 46 0.0009
534 DIARRHOEA 605 0.0009
535 NAUSEA 741 0.0009
536 ONYCHOMYCOSIS 4 0.0009
537 TOOTH INFECTION 12 0.0009
538 DECREASED APPETITE 211 0.0009
539 SEPSIS 101 0.0009
540 DYSPNOEA EXERTIONAL 34 0.0009
541 LEUKOPENIA 45 0.0009
542 FACIAL PAIN 8 0.0009
543 PNEUMONIA 289 0.0009
544 ANGIOPATHY 5 0.0009
545 HYPERCALCAEMIA 11 0.0009
546 RECTAL HAEMORRHAGE 38 0.0009
547 COUGH 248 0.0009
548 TOOTH ABSCESS 9 0.0009
549 NEUTROPHIL COUNT INCREASED 9 0.0009
550 CENTRAL NERVOUS SYSTEM LESION 12 0.0009
551 GENERAL PHYSICAL HEALTH DETERIORATION 101 0.0009
552 BLISTER 49 0.0009
553 COLON CANCER 13 0.0009
554 SENSORY DISTURBANCE 14 0.0009
555 MUSCULAR WEAKNESS 99 0.0009
556 VERTIGO 53 0.0009
557 ENCEPHALITIS 6 0.0009
558 PULMONARY HYPERTENSION 18 0.0009
559 TENDERNESS 9 0.0009
560 DRY EYE 43 0.0009
561 CARDIAC FAILURE 69 0.0009
562 COLITIS 32 0.0008
563 SARCOIDOSIS 4 0.0008
564 CARDIAC TAMPONADE 4 0.0008
565 SKIN DISORDER 28 0.0008
566 DRY SKIN 111 0.0008
567 MUSCLE TWITCHING 19 0.0008
568 BLOOD PRESSURE INCREASED 126 0.0008
569 NOCTURIA 10 0.0008
570 OESOPHAGITIS 9 0.0008
571 ASTHENIA 306 0.0008
572 BACK PAIN 189 0.0008
573 CHOLANGITIS 5 0.0008
574 INFUSION SITE EXTRAVASATION 5 0.0008
575 SKIN LESION 22 0.0008
576 FISTULA 9 0.0008
577 FEEDING DISORDER 16 0.0008
578 MASS 11 0.0008
579 HYPERTHERMIA 6 0.0008
580 LIPASE INCREASED 6 0.0008
581 HAEMOLYTIC ANAEMIA 7 0.0008
582 FEMORAL NECK FRACTURE 4 0.0008
583 DISEASE RECURRENCE 37 0.0008
584 FEMUR FRACTURE 24 0.0008
585 ALOPECIA 152 0.0008
586 UROSEPSIS 7 0.0008
587 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 13 0.0008
588 SCIATICA 12 0.0008
589 DEMENTIA 21 0.0008
590 PALPITATIONS 88 0.0008
591 BLOOD DISORDER 6 0.0007
592 VOMITING 352 0.0007
593 OXYGEN SATURATION DECREASED 42 0.0007
594 CHOLECYSTITIS CHRONIC 5 0.0007
595 OFF LABEL USE 647 0.0007
596 DIPLOPIA 19 0.0007
597 HEART RATE INCREASED 72 0.0007
598 DEAFNESS UNILATERAL 4 0.0007
599 HAEMOPTYSIS 20 0.0007
600 PERIPHERAL SWELLING 110 0.0007
601 PULMONARY ALVEOLAR HAEMORRHAGE 4 0.0007
602 BLOOD PRESSURE DECREASED 47 0.0007
603 CHOLECYSTITIS ACUTE 4 0.0007
604 DRUG INTOLERANCE 68 0.0007
605 SKIN HYPERPIGMENTATION 6 0.0007
606 HEADACHE 436 0.0007
607 LETHARGY 40 0.0007
608 EXERCISE TOLERANCE DECREASED 4 0.0007
609 DYSPEPSIA 68 0.0007
610 NEOPLASM MALIGNANT 46 0.0007
611 ABDOMINAL PAIN 160 0.0007
612 FRACTURE 13 0.0007
613 BLOOD CALCIUM INCREASED 6 0.0007
614 SPINAL OSTEOARTHRITIS 6 0.0007
615 RIB FRACTURE 14 0.0007
616 ACUTE RESPIRATORY DISTRESS SYNDROME 12 0.0007
617 THROAT IRRITATION 30 0.0007
618 PAIN OF SKIN 18 0.0007
619 HYDRONEPHROSIS 5 0.0007
620 RASH PRURITIC 36 0.0007
621 HYPOAESTHESIA ORAL 10 0.0007
622 PLATELET COUNT ABNORMAL 4 0.0007
623 LOCALISED INFECTION 16 0.0007
624 OPTIC NEURITIS 6 0.0007
625 DEATH 565 0.0007
626 FACE OEDEMA 11 0.0007
627 BLOOD THYROID STIMULATING HORMONE INCREASED 6 0.0007
628 HERPES ZOSTER 37 0.0006
629 SEPTIC SHOCK 28 0.0006
630 ERYTHEMA MULTIFORME 6 0.0006
631 TASTE DISORDER 13 0.0006
632 TOOTH FRACTURE 7 0.0006
633 HYPERGLYCAEMIA 23 0.0006
634 RENAL CYST 5 0.0006
635 TRICUSPID VALVE INCOMPETENCE 5 0.0006
636 SUBDURAL HAEMATOMA 9 0.0006
637 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 6 0.0006
638 ANGINA PECTORIS 18 0.0006
639 CYSTITIS 20 0.0006
640 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
641 HAEMOGLOBIN DECREASED 64 0.0006
642 HERPES SIMPLEX 4 0.0006
643 MYOCARDIAL ISCHAEMIA 7 0.0006
644 BLINDNESS 25 0.0006
645 EATING DISORDER 13 0.0006
646 FLUSHING 62 0.0006
647 SARS-COV-2 TEST POSITIVE 8 0.0006
648 DYSURIA 22 0.0006
649 VISION BLURRED 82 0.0006
650 HOT FLUSH 45 0.0006
651 EMPHYSEMA 6 0.0006
652 OSTEOPENIA 9 0.0006
653 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
654 OEDEMA 32 0.0006
655 MOTOR DYSFUNCTION 6 0.0006
656 RHINORRHOEA 38 0.0006
657 DEPRESSED MOOD 31 0.0006
658 MATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0006
659 VITAMIN D DECREASED 5 0.0006
660 PERIPHERAL COLDNESS 8 0.0006
661 ANAPHYLACTIC SHOCK 15 0.0006
662 CHOLELITHIASIS 19 0.0006
663 HYSTERECTOMY 5 0.0006
664 WEIGHT FLUCTUATION 6 0.0006
665 INFLUENZA LIKE ILLNESS 47 0.0006
666 ENCEPHALOPATHY 14 0.0006
667 SUDDEN DEATH 6 0.0006
668 IMMUNOSUPPRESSION 5 0.0006
669 HYPERTENSION 120 0.0006
670 DIVERTICULUM 4 0.0006
671 RESPIRATORY FAILURE 41 0.0006
672 OROPHARYNGEAL PAIN 52 0.0006
673 RETINAL HAEMORRHAGE 4 0.0006
674 PHARYNGITIS STREPTOCOCCAL 6 0.0006
675 PELVIC PAIN 10 0.0005
676 UNDERDOSE 40 0.0005
677 UTERINE LEIOMYOMA 4 0.0005
678 MELAENA 12 0.0005
679 PNEUMONIA BACTERIAL 5 0.0005
680 ANAPHYLACTIC REACTION 30 0.0005
681 INFLAMMATION 28 0.0005
682 HYPOPHOSPHATAEMIA 4 0.0005
683 CONTUSION 52 0.0005
684 NERVE INJURY 6 0.0005
685 RESPIRATORY TRACT INFECTION 14 0.0005
686 DYSPNOEA 304 0.0005
687 COVID-19 94 0.0005
688 OSTEOPOROSIS 22 0.0005
689 RASH 232 0.0005
690 SCAR 9 0.0005
691 PRODUCT STORAGE ERROR 46 0.0005
692 GASTRIC HAEMORRHAGE 6 0.0005
693 PANIC ATTACK 19 0.0005
694 DELIRIUM 18 0.0005
695 LYMPHOMA 8 0.0005
696 DEHYDRATION 69 0.0005
697 ELECTROLYTE IMBALANCE 6 0.0005
698 MUSCULOSKELETAL PAIN 27 0.0005
699 ACUTE HEPATIC FAILURE 7 0.0005
700 HYPOXIA 18 0.0005
701 PSYCHOTIC DISORDER 15 0.0005
702 CHEST PAIN 94 0.0005
703 BACTERAEMIA 6 0.0005
704 SKIN ULCER 13 0.0005
705 WOUND 14 0.0005
706 OEDEMA PERIPHERAL 61 0.0005
707 VISUAL IMPAIRMENT 62 0.0005
708 BRAIN INJURY 5 0.0005
709 CHEST DISCOMFORT 51 0.0005
710 HYPERSENSITIVITY 92 0.0005
711 HYPOTHERMIA 5 0.0005
712 INFLUENZA 55 0.0005
713 POST PROCEDURAL INFECTION 4 0.0005
714 ASPHYXIA 4 0.0005
715 PANCREATITIS ACUTE 11 0.0005
716 POLYURIA 4 0.0005
717 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
718 GENERALISED OEDEMA 6 0.0005
719 OCULAR HYPERAEMIA 23 0.0005
720 SPINAL COMPRESSION FRACTURE 4 0.0005
721 PHARYNGITIS 6 0.0005
722 PERITONITIS 10 0.0005
723 TOOTH LOSS 10 0.0005
724 WEIGHT INCREASED 108 0.0005
725 PAIN IN EXTREMITY 142 0.0005
726 EYE DISCHARGE 5 0.0005
727 CARDIAC DISORDER 45 0.0005
728 NEPHROLITHIASIS 22 0.0005
729 DYSPHONIA 28 0.0005
730 ARTHRALGIA 197 0.0005
731 PAIN 291 0.0005
732 GASTRIC ULCER 9 0.0005
733 INCONTINENCE 5 0.0005
734 MUSCLE SPASMS 86 0.0005
735 MENTAL DISORDER 20 0.0005
736 BLOOD CREATININE INCREASED 30 0.0005
737 JOINT STIFFNESS 12 0.0005
738 EMOTIONAL DISORDER 14 0.0005
739 ABDOMINAL DISTENSION 47 0.0004
740 PRODUCT ADMINISTRATION ERROR 9 0.0004
741 DYSGEUSIA 33 0.0004
742 HYPOTENSION 88 0.0004
743 SWELLING 41 0.0004
744 HAEMATURIA 15 0.0004
745 GASTROINTESTINAL DISORDER 39 0.0004
746 NIGHT SWEATS 14 0.0004
747 HAEMATEMESIS 11 0.0004
748 UPPER RESPIRATORY TRACT INFECTION 20 0.0004
749 AMNESIA 28 0.0004
750 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
751 BLINDNESS UNILATERAL 6 0.0004
752 ARTERIOSCLEROSIS 4 0.0004
753 LEUKAEMIA 4 0.0004
754 VISUAL ACUITY REDUCED 14 0.0004
755 DYSPHAGIA 40 0.0004
756 GASTRITIS 11 0.0004
757 DEEP VEIN THROMBOSIS 27 0.0004
758 THYROID CANCER 5 0.0004
759 VAGINAL HAEMORRHAGE 18 0.0004
760 INFECTION 60 0.0004
761 ATELECTASIS 4 0.0004
762 SKIN DISCOLOURATION 19 0.0004
763 HEMIPARESIS 7 0.0004
764 PULMONARY EMBOLISM 39 0.0004
765 BLOOD CHOLESTEROL INCREASED 19 0.0004
766 TOOTH EXTRACTION 5 0.0004
767 HYPOTONIA 4 0.0004
768 PNEUMONIA ASPIRATION 10 0.0004
769 RESPIRATORY DISTRESS 11 0.0004
770 THROMBOSIS 32 0.0004
771 DERMATITIS ALLERGIC 5 0.0004
772 MALAISE 174 0.0004
773 FEELING COLD 11 0.0004
774 INSOMNIA 105 0.0004
775 SUBARACHNOID HAEMORRHAGE 4 0.0004
776 SLUGGISHNESS 4 0.0004
777 VIRAL INFECTION 13 0.0004
778 ROTATOR CUFF SYNDROME 5 0.0004
779 DIZZINESS 194 0.0004
780 TEMPERATURE INTOLERANCE 4 0.0004
781 POOR VENOUS ACCESS 4 0.0004
782 BRAIN FOG 6 0.0004
783 IMMUNE SYSTEM DISORDER 5 0.0004
784 SCRATCH 4 0.0004
785 COMA 18 0.0004
786 RENAL PAIN 4 0.0004
787 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
788 HYPOTHYROIDISM 12 0.0004
789 RETCHING 8 0.0004
790 DYSARTHRIA 14 0.0004
791 SKIN CANCER 8 0.0004
792 TACHYCARDIA 33 0.0004
793 BLOOD URINE PRESENT 7 0.0004
794 PROTEINURIA 7 0.0004
795 RESPIRATORY DISORDER 11 0.0004
796 COGNITIVE DISORDER 17 0.0004
797 ACUTE CORONARY SYNDROME 3 0.0004
798 DENTAL CARIES 4 0.0004
799 DISCOMFORT 22 0.0004
800 VENTRICULAR FIBRILLATION 4 0.0004
801 POLLAKIURIA 15 0.0004
802 KIDNEY INFECTION 7 0.0004
803 HYPOPHAGIA 9 0.0004
804 ABDOMINAL PAIN UPPER 72 0.0003
805 GASTROOESOPHAGEAL REFLUX DISEASE 28 0.0003
806 FULL BLOOD COUNT DECREASED 7 0.0003
807 SPEECH DISORDER 18 0.0003
808 MEMORY IMPAIRMENT 47 0.0003
809 ERYTHEMA 70 0.0003
810 ISCHAEMIC STROKE 6 0.0003
811 CARDIAC FAILURE CONGESTIVE 27 0.0003
812 BALANCE DISORDER 29 0.0003
813 IMMUNODEFICIENCY 5 0.0003
814 HAEMORRHAGE 35 0.0003
815 ANAL INCONTINENCE 3 0.0003
816 MOUTH ULCERATION 7 0.0003
817 APHASIA 10 0.0003
818 FUNGAL INFECTION 11 0.0003
819 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
820 TYPE 2 DIABETES MELLITUS 11 0.0003
821 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
822 PRURITUS 125 0.0003
823 INTERCEPTED PRODUCT PREPARATION ERROR 4 0.0003
824 GASTROINTESTINAL HAEMORRHAGE 27 0.0003
825 NECK PAIN 18 0.0003
826 LUNG INFECTION 5 0.0003
827 GASTRIC DISORDER 11 0.0003
828 MENINGIOMA 5 0.0003
829 ARRHYTHMIA 15 0.0003
830 MUSCLE ATROPHY 4 0.0003
831 RASH MACULO-PAPULAR 7 0.0003
832 THERAPEUTIC RESPONSE DECREASED 19 0.0003
833 RENAL IMPAIRMENT 26 0.0003
834 DRUG INEFFECTIVE 406 0.0003
835 OSTEOARTHRITIS 13 0.0003
836 BEDRIDDEN 4 0.0003
837 STAPHYLOCOCCAL INFECTION 10 0.0003
838 SYNCOPE 30 0.0003
839 EYE HAEMORRHAGE 4 0.0003
840 GAIT INABILITY 10 0.0003
841 THROAT TIGHTNESS 8 0.0003
842 TREMOR 48 0.0003
843 MEDICATION ERROR 16 0.0003
844 COORDINATION ABNORMAL 4 0.0003
845 CEREBRAL INFARCTION 7 0.0003
846 BURNING SENSATION 20 0.0003
847 SKIN REACTION 4 0.0003
848 HEAD DISCOMFORT 5 0.0003
849 SINUS TACHYCARDIA 4 0.0003
850 LEUKOCYTOSIS 5 0.0003
851 CARDIOVASCULAR DISORDER 7 0.0003
852 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8 0.0003
853 HAEMATOMA 7 0.0003
854 AGRANULOCYTOSIS 5 0.0003
855 BACTERIAL INFECTION 5 0.0003
856 HAEMORRHAGE INTRACRANIAL 4 0.0003
857 THERAPY NON-RESPONDER 12 0.0003
858 INTENTIONAL PRODUCT MISUSE 23 0.0003
859 ACUTE KIDNEY INJURY 40 0.0003
860 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
861 ANXIETY 74 0.0003
862 TENDONITIS 4 0.0003
863 INJURY 18 0.0003
864 ULCER 4 0.0003
865 PRODUCTIVE COUGH 12 0.0003
866 UPPER LIMB FRACTURE 5 0.0003
867 GAIT DISTURBANCE 48 0.0003
868 PRODUCT USE ISSUE 47 0.0002
869 BLOOD PRESSURE FLUCTUATION 6 0.0002
870 PREGNANCY 5 0.0002
871 ADRENAL INSUFFICIENCY 3 0.0002
872 THERAPEUTIC PRODUCT EFFECT DECREASED 11 0.0002
873 IMPAIRED HEALING 8 0.0002
874 FALL 81 0.0002
875 EYE DISORDER 8 0.0002
876 LUNG NEOPLASM MALIGNANT 10 0.0002
877 TOXICITY TO VARIOUS AGENTS 41 0.0002
878 SLEEP DISORDER 17 0.0002
879 URINARY RETENTION 8 0.0002
880 BLOOD UREA INCREASED 4 0.0002
881 EYE PRURITUS 8 0.0002
882 PERICARDITIS 4 0.0002
883 INJECTION SITE HAEMORRHAGE 19 0.0002
884 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
885 CEREBROVASCULAR ACCIDENT 40 0.0002
886 MUSCULOSKELETAL DISCOMFORT 4 0.0002
887 HYPOACUSIS 10 0.0002
888 FAECES DISCOLOURED 5 0.0002
889 BLOOD GLUCOSE DECREASED 11 0.0002
890 PANCREATITIS 12 0.0002
891 SKIN EXFOLIATION 19 0.0002
892 SINUSITIS 23 0.0002
893 RASH PAPULAR 5 0.0002
894 CHROMATURIA 5 0.0002
895 OSTEOMYELITIS 4 0.0002
896 HIP FRACTURE 7 0.0002
897 MUSCULOSKELETAL STIFFNESS 19 0.0002
898 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
899 CONFUSIONAL STATE 34 0.0002
900 MUSCULOSKELETAL DISORDER 4 0.0002
901 RASH ERYTHEMATOUS 10 0.0002
902 MOBILITY DECREASED 15 0.0002
903 OVERDOSE 45 0.0002
904 SOMNOLENCE 42 0.0002
905 SURGERY 12 0.0002
906 DRUG EFFECT DECREASED 11 0.0002
907 MENORRHAGIA 4 0.0002
908 LOSS OF CONSCIOUSNESS 26 0.0002
909 AGEUSIA 5 0.0002
910 MIGRAINE 19 0.0002
911 CORONARY ARTERY DISEASE 6 0.0002
912 ARTHROPATHY 11 0.0002
913 DIABETES MELLITUS 15 0.0002
914 ILLNESS 20 0.0002
915 CONDITION AGGRAVATED 59 0.0002
916 ANKLE FRACTURE 3 0.0002
917 DEAFNESS 5 0.0002
918 MATERNAL EXPOSURE DURING PREGNANCY 17 0.0002
919 EAR INFECTION 5 0.0002
920 INTESTINAL OBSTRUCTION 7 0.0002
921 PALLOR 5 0.0002
922 OSTEONECROSIS 6 0.0002
923 PROCEDURAL PAIN 5 0.0002
924 DEPRESSION 41 0.0002
925 HYPERHIDROSIS 23 0.0002
926 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
927 BRONCHITIS 13 0.0002
928 DYSSTASIA 5 0.0002
929 AMENORRHOEA 3 0.0002
930 CARDIAC ARREST 14 0.0002
931 CARDIO-RESPIRATORY ARREST 7 0.0002
932 DISTURBANCE IN ATTENTION 9 0.0002
933 ABASIA 4 0.0002
934 EYE PAIN 9 0.0002
935 URTICARIA 26 0.0002
936 ABDOMINAL DISCOMFORT 26 0.0002
937 BLOOD GLUCOSE INCREASED 29 0.0002
938 SKIN BURNING SENSATION 11 0.0002
939 TINNITUS 7 0.0002
940 RENAL FAILURE 20 0.0002
941 BREAST CANCER FEMALE 4 0.0001
942 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
943 ANGER 5 0.0001
944 FEELING HOT 9 0.0001
945 MOOD ALTERED 4 0.0001
946 RESPIRATORY ARREST 4 0.0001
947 MENTAL STATUS CHANGES 4 0.0001
948 FEELING ABNORMAL 34 0.0001
949 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
950 EYE IRRITATION 8 0.0001
951 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
952 SWELLING FACE 9 0.0001
953 NEEDLE ISSUE 4 0.0001
954 PRODUCT USE IN UNAPPROVED INDICATION 34 0.0001
955 NASAL CONGESTION 8 0.0001
956 ANGIOEDEMA 6 0.0001
957 EYE SWELLING 5 0.0001
958 TREATMENT FAILURE 11 0.0001
959 UNEVALUABLE EVENT 10 0.0001
960 DRUG ADMINISTRATION ERROR 4 0.0001
961 ARTHRITIS 10 0.0001
962 DRUG INTERACTION 20 0.0001
963 MOVEMENT DISORDER 4 0.0001
964 ATRIAL FIBRILLATION 12 0.0001
965 WHEEZING 7 0.0001
966 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
967 ADVERSE DRUG REACTION 10 0.0001
968 RENAL DISORDER 5 0.0001
969 FLATULENCE 6 0.0001
970 ACUTE MYOCARDIAL INFARCTION 3 0.0001
971 JOINT SWELLING 11 0.0001
972 HAEMATOCHEZIA 5 0.0001
973 INCORRECT DOSE ADMINISTERED 20 0.0001
974 CONVULSION 5 0.0001
975 SKIN IRRITATION 4 0.0001
976 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
977 MULTIPLE SCLEROSIS 4 0.0001
978 ACNE 6 0.0001
979 ADVERSE EVENT 7 0.0001
980 ABORTION SPONTANEOUS 3 0.0001
981 ASTHMA 8 0.0001
982 RHEUMATOID ARTHRITIS 8 0.0001
983 THERAPY INTERRUPTED 5 0.0001
984 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 14 0.0001
985 MYOCARDIAL INFARCTION 11 0.0001
986 INJECTION SITE ERYTHEMA 7 0.0001
987 DEVICE ISSUE 5 0.0001
988 HALLUCINATION 4 0.0001
989 EMOTIONAL DISTRESS 6 0.0000
990 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
991 HOSPITALISATION 4 0.0000
992 DRUG DOSE OMISSION 4 0.0000
993 PRODUCT DOSE OMISSION ISSUE 7 0.0000
994 INJECTION SITE PAIN 4 0.0000